Inclusion Criteria:  Patients ≥ 18 years of age. Diagnosis of rheumatic disease treated or not with immunosuppressive agents Patients who have received at least one dose of a SARS-CoV-2 vaccine Signature of informed consent.  Exclusion Criteria:  Patients who express their desire not to participate in the study or who are unable to give their informed consent.